Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. E.M.D. (Ed) Schuuring


A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland

Association of Tumor Microenvironment with Biological and Chronological Age in Head and Neck Cancer

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Read more


Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging

“Betere diagnostiek verhoogt overlevingskans”

Read more